The potent transforming activity of membrane-targeted Raf-1 (Raf-CAAX) suggests that Ras transformation is triggered primarily by a Ras-mediated translocation of Raf-1 to the plasma membrane. However, whereas constitutively activated mutants of Ras The precise mechanism by which Ras triggers Raf-1 activation remains to be determined. However, the recent demonstration that addition of the Ras COOH-terminal plasma membrane targeting sequence to Raf-1 converted it to a potent transforming protein suggested that Ras transformation is mediated, in large part, by promoting the translocation of Raf-1 to the plasma membrane (11, 12) . Once at the membrane, additional Ras-independent events occur to complete the activation of Raf-1 kinase activity (13, 14) . These observations, taken together with the comparable transforming potencies and properties of activated Ras and Raf-1 in rodent fibroblast transformation assays, support the possibility that Ras transformation is mediated solely through activation of the Raf-1/MAP kinase cascade in these cells.
indistinguishable morphologic and growth (in soft agar and nude mice) transformation of NIH 3T3 fibroblasts, only mutant Ras caused morphologic transformation of RIE-1 rat intestinal cells. Furthermore, only mutant Ras-expressing RIE-1 cells formed colonies in soft agar and developed rapid and progressive tumors in nude mice. We also observed that activated Ras, but not Raf-1, caused transformation of IEC-6 rat intestinal and MCF-1OA human mammary epithelial cells. Although both Ras-and ARaf-22W-expressing RIE-1 cells showed elevated Raf-1 and mitogen-activated protein (MAP) kinase activities, only Ras-transformed cells produced secreted factors that promoted RIE-1 transformation. Incubation of untransformed RIE-1 cells in the presence of conditioned medium from Ras-expressing, but not ARaf-22W-expressing, cells caused a rapid and stable morphologic transformation that was indistinguishable from the morphology of Ras-transformed RIE-1 cells. Thus, induction of an autocrine growth mechanism may distinguish the transforming actions of Ras and Raf. In summary, our observations demonstrate that oncogenic Ras activation of the Raf/MAP kinase pathway alone is not sufficient for full tumorigenic transformation of RIE-1 epithelial cells. Thus, Rafindependent signaling events are essential for oncogenic Ras transformation of epithelial cells, but not fibroblasts.
Ras proteins are GDP/GTP-regulated switches that function downstream of receptor tyrosine kinases and upstream of a cascade of serine/threonine kinases that include the mitogenactivated protein (MAP) kinases (1) (2) (3) . Upon activation by ligand-stimulated receptors, activated Ras complexes with and promotes the activation of the Raf-1 serine/threonine kinase. Raf-1 then activates MAP kinase kinases (MEK1 and MEK2), which in turn activate p42 and p44 MAP kinases also referred to as extracellular signal regulated kinases (ERKs). The central role of the Raf-1/MAP kinase pathway in Ras-mediated transformation of fibroblasts is supported by the observations that kinase-deficient mutants of Raf-1, MEK, and MAP kinases are potent inhibitors of Ras signal transduction and transformation (4) (5) (6) (7) (8) (9) . Furthermore, since constitutively activated mutants of Raf-1 or MEK cause tumorigenic transformation of NIH 3T3 cells (4, 5, 10) , activation of the Raf-1/ MAP kinase pathway alone is believed to be sufficient to mediate Ras transforming activity.
The precise mechanism by which Ras triggers Raf-1 activation remains to be determined. However, the recent demonstration that addition of the Ras COOH-terminal plasma membrane targeting sequence to Raf-1 converted it to a potent transforming protein suggested that Ras transformation is mediated, in large part, by promoting the translocation of Raf-1 to the plasma membrane (11, 12) . Once at the membrane, additional Ras-independent events occur to complete the activation of Raf-1 kinase activity (13, 14) . These observations, taken together with the comparable transforming potencies and properties of activated Ras and Raf-1 in rodent fibroblast transformation assays, support the possibility that Ras transformation is mediated solely through activation of the Raf-1/MAP kinase cascade in these cells.
Despite evidence that Raf-1 is a critical downstream target for Ras, there is increasing evidence that Ras may mediate its actions by stimulating multiple downstream targets, of which Raf-1 is only one. First, the recent identification of a mutant Ras protein that failed to bind Raf-1 yet retained signaling activities that contribute to Ras transformation suggested that Raf-1-independent pathways are also important for promoting full Ras transformation (15) . Second, genetic studies of S. pombe Ras (rasl) function have identified two distinct rasl effector-mediated activities (16) . One involves rasl interaction with byr2 (a MEK kinase homolog), and the other is triggered by rasl interaction with scdl (a putative Rho quanine nucleotide exchange factor). scdl in turn may regulate the function of the cdc42sp Rho family protein. Evidence that Ras transformation is also mediated by Rho family proteins in mammalian cells includes recent observations that the function of three Rho family proteins (RhoA, RhoB, and Racl) are necessary for full Ras transforming activity (17) (18) (19) . Finally, the increasing number of candidate Ras effectors provides additional support for the existence of Raf-independent Ras signaling pathways (20) . Included in this expanding roster of functionally diverse proteins are the two Ras GTPase activating proteins (p120 and NF1 GTPase activating proteins), two guanine nucleotide exchange factors of the Ras-related proteins RalA and RalB (RalGDS and RGL) (21) (22) (23) and phosphatidylinositol-3-OH kinase (24) . Like Raf-1, these proteins show preferential binding to active Ras-GTP and require an intact Ras effector domain (residues 32-40) for this interaction. Presently, the contribution of these candidate effectors to Ras signal transduction and transformation has not been determined.
Although mutant Ras is most frequently associated with epithelial cell-derived tumors (25) , the majority of Ras signal transduction and transformation studies have been performed in rodent fibroblast cells (1) (2) (3) . Therefore, we were interested in addressing the possibility that the signaling pathways in- MATERIALS AND METHODS Molecular Constructs. Mammalian expression vectors containing cDNA sequences for human H-ras, K-ras4B, and c-raf-1 were generated using the pZIP-NeoSV(x)l retrovirus vector (neomycin resistant), where expression of the inserted gene is regulated from the Moloney long terminal repeat promoter. The pZIP-rasH(61L) and pZIP-rasK(12V) retrovirus expression vector constructs, which encode transforming mutants of human H-Ras(61L) and K-Ras(12V), respectively, have been described (26, 27) . pZIP-Araf22W and pZIP-raf-CAAX encode transforming mutants of human c-Raf-1. ARaf-22W is activated by NH2-terminal truncation (28), whereas Raf-CAAX is a chimeric protein that contains the COOHterminal 18-aa plasma membrane-targeting sequence from K-Ras4B at the COOH terminus of full-length human Raf-1. Recent studies have shown that membrane-targeted Raf-1 shows potent transforming activity in NIH 3T3 cells (11, 12) .
Cell Culture and Transformation Assays. RIE-1 rat intestinal epithelial cells were maintained in DMEM supplemented with 5% fetal calf serum. DNA transfections (0.1-10 ,ug of plasmid DNA per 60-mm dish) were done using 5 ,ul of Lipofectamine (GIBCO/BRL) for 16-20 hr on cells seeded at 1-5 x 105 per 60-mm dish. NIH 3T3 cells were grown in DMEM supplemented with 10% calf serum. DNA transfections (10-25 ng plasmid DNA per 60-mm dish) were done using calcium phosphate precipitation (29) . Transformed foci were quantitated 21 (RIE-1) or 14-16 (NIH 3T3) days after transfection. Representative dishes were stained with crystal violet to visualize transformed foci.
To isolate cell lines stably expressing mutant Ras or Raf-1 proteins, NIH 3T3 and RIE-1 cultures were transfected with the neo-resistant pZIP expression plasmids and were maintained in growth medium supplemented with 400 ,ug/ml G418 (GIBCO/BRL). Multiple G418-resistant colonies were then pooled together (>50 colonies) and used for growth transformation assays. To assess colony formation in soft agar, each transfected cell line was seeded at 103 to 104 cells per 60-mm dish in growth medium containing 0.3% agar over a base layer of 0.6%. Tumorigenic growth potential of the transfected RIE-1 cells was determined by subcutaneous inoculation into athymic nude mice (1 X 106 cells per site) using procedures that we have described previously (29 1996) mined the sensitivity of RIE-1 cells to transformation by constitutively activated mutants of Ras and Raf-1. For these analyses, we used expression vectors that encoded oncogenic H-Ras(61L) or K-Ras4B(12V) and two different activated mutants of Raf-1 (ARaf-22W and Raf-CAAX). The Ras and Raf expression vectors were previously shown to cause comparable focus-forming activities in NIH 3T3 assays (3-4 x 103 foci/,ug or 1-2 x 103 foci/gg of transfected plasmid DNA, respectively) (26, 28) . Surprisingly, whereas oncogenic mutants of Ras readily induced transformed foci in RIE-1 cultures that were transfected with as little as 100 ng of plasmid DNA ('50 foci/,tg of DNA) (Fig. 1A) , no focus-forming activity was observed in cultures transfected with up to 10 ,tg of plasmid DNA encoding the two Raf-1 mutants (Fig. 1B) (11, 12, 28) . Thus, activated Raf-1, but not Ras, showed differential abilities to cause focus-formation in RIE-1 and NIH 3T3 cells.
We next evaluated the biological properties of RIE-1 cells stably transfected with constructs encoding the different transforming mutants of Ras and Raf-1. Whereas untransformed RIE-1 cells displayed a very flat, well-adherent and nonrefractile appearance, Ras-transformed RIE-1 cells were very refractile and poorly adherent (Fig. 24) . In contrast, the morphology of ARaf-22W-or Raf-CAAX-transfected cells was indistinguishable from the control RIE-1 cells, which were transfected with the empty pZIP-NeoSV(x)l retrovirus ex- RIE-1 (and NIH 3T3) cells and suggests that the biological properties of these two Raf-1 mutants are not identical. Whereas RIE-1 cultures transfected with either empty vector, pZIP-ras, or pZIP-Araf22W, followed by selection in G418-containing growth medium, resulted in the efficient appearance of drug-resistant colonies, a considerably reduced frequency of colonies was observed with cultures transfected with pZIP-raf-CAAX (data not shown). However, the high levels of ARaf-22W expression indicate that the failure of this mutant to cause transformation is not due to lack of expression. Neither NH2-terminal truncation (ARaf-22W) nor the addition of a plasma membrane targeting sequence (Raf-CAAX) alone is sufficient to activate Raf-1 kinase activity (13, 14) . Thus, it is possible that other events required to trigger the activation of ARaf-22W or Raf-CAAX transforming activity may not occur in RIE-1 cells (14) . To address this possibility, we measured Raf-1 kinase activity in Ras-and Raf-expressing cells using an in vitro MEK-dependent MAP kinase phosphorylation assay. Whereas Raf-1 kinase activity was low in control, vector-transfected cells, Raf-1 kinase activity was greatly elevated in both oncogenic Ras-and ARaf-22W-expressing cells (Fig. 3B) . Additionally, we detected low levels of constitutively activated MAP kinase activity in both Ras-and Raf-expressing cells by the appearance of the slower migrating, phosphorylated and activated forms of p42 and p44 (Fig. 3C ) and by using a MAP kinase immune-complex kinase assay (data not shown). Thus, constitutive Raf and MAP kinase activity alone is not sufficient for transformation of RIE-1 cells, and Ras may trigger the stimulation of Raf/MAP kinase-independent events to promote tumorigenic transformation of RIE-1 cells.
Since up-regulation of TGF-a has been observed in Rastransformed IEC-18 rat intestinal epithelial cells (33) , we evaluated the possibility that the induction of an autocrine growth mechanism may distinguish the transforming activities of Ras and Raf-1 in RIE-1 cells. Whereas conditioned medium from vector-transfected cells showed no activity when added on to untransformed RIE-1 cells, conditioned medium from Ras-transformed cells caused a very dramatic morphologic A B 4op .
_ I go transformation that was indistinguishable from the highly refractile and rounded morphology of Ras-transformed RIE-1 cells (Fig. 4) . In contrast, conditioned medium from ARaf-22W-expressing cells did not cause morphologic transformation of RIE-1 cells. Finally, since we have observed that TGF-a expression is enhanced 50-fold in oncogenic Ras-expressing, but not ARaf-22W-expressing, RIE-1 cells (unpublished data), we determined whether TGF-a alone could cause the same changes as conditioned medium from Ras-transformed cells. Although growth of untransformed cells in the presence of 20 ng/ml TGF-a resulted in morphologic transformation, the effect was only transient (<24 hr) and distinct from the persistent changes that were seen with the conditioned medium from Ras-transformed cells. Therefore, although we have observed that TGF-a alone is sufficient to promote the growth of untransformed RIE-1 cells in soft agar (data not shown), TGF-a is not likely to be the only component present in the conditioned medium that contributes to RIE-1 transformation. We conclude that constitutive activation of Ras, but not Raf-1, causes induction of an autocrine mechanism that may contribute significantly to transformation of RIE-1 cells.
DISCUSSION
Since constitutive activation of either Ras or Raf-1 causes full tumorigenic transformation of NIH 3T3 fibroblasts, it has been suggested that oncogenic Ras causes transformation solely by promoting activation of the Raf/MAP kinase cascade (11, 12 
